| 8/15/2024 | IG | New Issue: Quest Diagnostics sells $1.85 billion of notes due 2027, 2029, 2034
|
| 8/15/2024 | BKIG | Moody’s gives Quest notes Baa1
|
| 8/15/2024 | BKIG | S&P assigns BBB+ to Quest notes
|
| 8/15/2024 | BKIG | Fitch rates Quest Diagnostics notes BBB
|
| 8/15/2024 | IG | Quest Diagnostics kicks off note offering to fund LifeLabs purchase
|
| 7/3/2024 | BKCAIG | Quest Diagnostics will take on debt to buy LifeLabs for C$1.35 billion
|
| 5/13/2024 | BKIG | Moody's upgrades Quest Diagnostics
|
| 10/30/2023 | IG | New Issue: Quest Diagnostics prices $750 million of 6.4% notes due 2033 at 153 bps spread
|
| 10/30/2023 | BKIG | Fitch gives Quest Diagnostics notes BBB
|
| 10/30/2023 | BKIG | S&P assigns BBB+ to Quest notes
|
| 10/30/2023 | BKIG | Moody’s rates Quest notes Baa2
|
| 10/30/2023 | IG | Quest Diagnostics to price senior notes via five bookrunners
|
| 5/24/2023 | BKIG | Moody’s alters Quest outlook to positive
|
| 5/8/2023 | BKIG | Fitch revises Quest view to positive
|
| 5/11/2020 | IG | Market Commentary: Disney, PayPal, Fiserv, Nutrien, Suncor, ITC, Regency, Quest price; EBRD, Cades on deck
|
| 5/11/2020 | IG | New Issue: Quest Diagnostics prices $550 million of 2.8% notes due 2031 at 210 bps spread
|
| 5/11/2020 | BKIG | Moody’s assigns Quest notes Baa2
|
| 5/11/2020 | BKIG | Fitch rates Quest notes BBB
|
| 5/11/2020 | IG | Market Commentary: Morning Commentary: Disney, PayPal, Nutrien, Fiserv, Suncor, EBRD, Cades on deck
|
| 5/11/2020 | BKIG | S&P gives Quest notes BBB+
|
| 5/11/2020 | IG | Quest Diagnostics to price senior notes via five bookrunners
|
| 4/22/2020 | BKBWIG | Quest may tap high-grade debt markets if it can’t access facilities
|
| 12/9/2019 | IG | Market Commentary: Steel Dynamics, Quest Diagnostics, Welltower, BP Capital price; Apollo markets dollar notes
|
| 12/9/2019 | IG | New Issue: Quest Diagnostics prices $800 million of 2.95% notes due 2030 at 115 bps spread
|
| 12/9/2019 | BKIG | Moody’s rates Quest notes Baa2
|
| 12/9/2019 | IG | S&P assigns BBB+ to Quest notes
|
| 12/9/2019 | IG | Fitch gives Quest Diagnostics notes BBB
|
| 12/9/2019 | IG | Market Commentary: Morning Commentary: Steel Dynamics, Quest Diagnostics, Welltower on tap; light supply eyed
|
| 12/9/2019 | IG | Quest Diagnostics to price senior notes via five bookrunners
|
| 7/16/2019 | IG | Fitch affirms Quest Diagnostics
|
| 3/7/2019 | IG | Market Commentary: Quest sets terms for $500 million sale of notes due 2029; Marriott, Dell price deals
|
| 3/7/2019 | IG | New Issue: Quest Diagnostics sells $500 million 4.2% notes due 2029 at 160 bps over Treasuries
|
| 3/7/2019 | IG | Moody's rates Quest notes Baa2
|
| 3/7/2019 | IG | Fitch rates Quest notes BBB
|
| 3/7/2019 | IG | S&P rates Quest notes BBB+
|
| 3/7/2019 | IG | Market Commentary: Morning Commentary: Quest Diagnostics to price $500 million of notes; issuance slows
|
| 3/7/2019 | IG | Quest Diagnostics to price $500 million of 10-year senior notes
|
| 7/16/2018 | IG | DBRS lowers Inter Pipeline
|
| 7/16/2018 | IG | Fitch affirms Quest Diagnostics
|
| 5/23/2016 | IG | Market Commentary: Lam Research, Santander, Dominion, USAA, Quest among day’s issuers; credit spreads mostly flat
|
| 5/23/2016 | IG | New Issue: Quest Diagnostics sells $500 million 3.45% 10-year notes at 165 bps over Treasuries
|
| 5/23/2016 | BKIG | S&P gives BBB+ to Quest notes
|
| 5/23/2016 | CVIG | Moody’s rates Quest notes Baa2
|
| 5/23/2016 | CVIG | Fitch rates Quest notes BBB
|
| 5/23/2016 | IG | Quest Diagnostics to offer $500 million of 10-year senior notes
|
| 3/29/2016 | IGLM | Quest Diagnostics holders tender $266.86 million 6.95%, 5.75% notes
|
| 3/28/2016 | IGLM | Quest Diagnostics prices tender for $200 million of 6.95%, 5.75% notes
|
| 3/15/2016 | IGLM | Quest Diagnostics offers to buy $200 million of 6.95%, 5.75% notes
|
| 4/30/2015 | BKCVIG | S&P lifts Quest view to stable
|
| 4/10/2015 | IGLM | Quest Diagnostics redeems some 3.2% notes, all 5.45% and 6.4% notes
|
| 3/19/2015 | IGLM | Quest hits tender offer cap for 6.95%, 5.75% notes by early deadline
|
| 3/18/2015 | IGLM | Quest Diagnostics prices tender offers for 6.95% notes, 5.75% notes
|
| 3/5/2015 | IGLM | Quest Diagnostics tenders for $250 million of 6.95% notes, 5.75% notes
|
| 3/5/2015 | IG | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
| 3/5/2015 | IG | New Issue: Quest Diagnostics sells $1.2 billion of notes in five-, 10-, 30-year tranches
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s gives Baa2 to Quest Diagnostics notes
|
| 3/5/2015 | BKIG | Fitch rates Quest bond BBB
|
| 3/5/2015 | BKIG | S&P rates Quest notes BBB+
|
| 3/5/2015 | IGLM | Quest Diagnostics tenders for $250 million of 6.95% notes, 5.75% notes
|
| 3/5/2015 | IG | Quest preps $1.2 billion of notes in five-, 10-, 30-year tranches; pricing Thursday
|
| 3/12/2014 | IG | Quest preps $600 million of senior notes in five-, 10-year tranches
|
| 3/12/2014 | IG | Market Commentary: EnLink, Nomura price as week's total nears $30 billion; energy bonds tighten
|
| 3/12/2014 | BKCVIG | Fitch downgrades Quest
|
| 3/12/2014 | BKCVIG | S&P rates Quest notes BBB+
|
| 3/12/2014 | BKIG | Moody's gives Quest notes Baa2
|
| 3/12/2014 | IG | New Issue: Quest prices $600 million of senior notes in five-, 10-year tranches
|
| 1/23/2014 | BKCVIG | Fitch: Quest on negative watch
|
| 10/25/2013 | IG | S&P: Quest view to negative
|
| 2/22/2013 | CVIG | Fitch: Quest outlook stable
|
| 2/22/2012 | CVIG | Fitch affirms Quest
|
| 3/25/2011 | IG | Correction: Quest Diagnostics' 10-year tranche of notes totaled $550 million
|
| 3/21/2011 | IG | New Issue: Quest Diagnostics prices massive $1.25 billion deal in four parts
|
| 3/21/2011 | IG | Market Commentary: Upbeat tone leads SunTrust, KeyCorp, Quest, Daimler to primary; AT&T, telecom bonds widen
|
| 3/21/2011 | CVIG | S&P rates Quest notes BBB+
|
| 3/21/2011 | CVIG | Moody's: Quest notes Baa2
|
| 3/21/2011 | CVIG | Fitch rates Quest notes BBB+
|
| 3/18/2011 | CVIG | Moody's: Quest unchanged
|
| 2/25/2011 | CVIG | Fitch cuts Quest to negative
|
| 2/24/2011 | CVIG | Moody's: Quest unchanged
|
| 2/2/2011 | CVIG | Fitch affirms Quest
|
| 2/1/2011 | CVIG | Moody's: Quest unaffected
|
| 8/11/2010 | CVIG | Fitch affirms Quest Diagnostics
|
| 6/17/2010 | IG | Quest Diagnostics files automatic shelf covering debt securities
|
| 2/9/2010 | IG | Moody's boosts Quest Diagnostics
|
| 1/25/2010 | BWIG | Quest Diagnostics to use cash for growth, enhancing shareholder value
|
| 11/20/2009 | IG | Quest Diagnostics receives tenders for 26.87% of 5.125% notes, 35.94% of 7.5% notes
|
| 11/17/2009 | IG | Quest prices tender offer for any and all of its 5.125%, 7.5% notes
|
| 11/16/2009 | IG | Market Commentary: Westpac, Progress, BBVA, Kellogg among issuers; new deals trade briskly, secondary volume light
|
| 11/13/2009 | IG | Market Commentary: Lockheed Martin, Thermo Fisher sell bonds; Universal eyes split-rated sale; new deals flat
|
| 11/12/2009 | IG | S&P rates Quest notes BBB+
|
| 11/12/2009 | IG | Fitch rates Quest notes BBB+
|
| 11/12/2009 | IG | Market Commentary: Quest Diagnostics, Zimmer, Raytheon, Waste Management among day's sales; spreads ease
|
| 11/12/2009 | IG | New Issue: Quest Diagnostics sells $750 million notes in 10-, 30-year tranches
|
| 9/21/2009 | IG | Moody's ups Quest outlook to positive
|
| 8/14/2009 | IG | Fitch rates Quest BBB+
|
| 6/17/2009 | IG | Quest completes tender for up to $200 million of 5.125%, 7.5% notes
|
| 6/12/2009 | IG | Quest prices tender offer for up to $200 million of 5.125%, 7.5% notes
|
| 6/9/2009 | IG | Quest Diagnostics sees significant opportunity to grow internationally
|
| 6/3/2009 | IG | Quest Diagnostics gives early tender results for 5.125%, 7.5% notes
|
| 4/15/2009 | IG | Moody's: Quest unaffected
|
| 7/2/2008 | IG | S&P lifts Quest Diagnostics outlook to stable
|
